Year |
Citation |
Score |
2021 |
Guo S, Nguyen L, Ranum LPW. RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies. Current Opinion in Neurobiology. 72: 160-170. PMID 34953315 DOI: 10.1016/j.conb.2021.11.001 |
0.372 |
|
2021 |
Tusi SK, Nguyen L, Thangaraju K, Li J, Cleary JD, Zu T, Ranum LPW. The alternative initiation factor eIF2A plays key role in RAN translation of myotonic dystrophy type 2 CCUG•CAGG repeats. Human Molecular Genetics. PMID 33856033 DOI: 10.1093/hmg/ddab098 |
0.399 |
|
2020 |
Zu T, Guo S, Bardhi O, Ryskamp DA, Li J, Khoramian Tusi S, Engelbrecht A, Klippel K, Chakrabarty P, Nguyen L, Golde TE, Sonenberg N, Ranum LPW. Metformin inhibits RAN translation through PKR pathway and mitigates disease in ALS/FTD mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 32690681 DOI: 10.1073/Pnas.2005748117 |
0.393 |
|
2017 |
DiGiacomo V, de Opakua AI, Papakonstantinou MP, Nguyen LT, Merino N, Blanco-Canosa JB, Blanco FJ, Garcia-Marcos M. The Gαi-GIV binding interface is a druggable protein-protein interaction. Scientific Reports. 7: 8575. PMID 28819150 DOI: 10.1038/s41598-017-08829-7 |
0.327 |
|
2016 |
Bai Y, Nguyen LT, Song Z, Peng S, Lee J, Zheng N, Kapoor I, Hagler LD, Cai K, Cheng J, Chan HY, Zimmerman SC. Integrating Display and Delivery Functionality with a Cell Penetrating Peptide Mimic as a Scaffold for Intracellular Multivalent Multi-targeting. Journal of the American Chemical Society. PMID 27355522 DOI: 10.1021/Jacs.6B03697 |
0.691 |
|
2016 |
Luu LM, Nguyen L, Peng S, Lee J, Lee HY, Wong CH, Hergenrother PJ, Chan HY, Zimmerman SC. A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy. Chemmedchem. PMID 27245480 DOI: 10.1002/Cmdc.201600081 |
0.658 |
|
2015 |
Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC. Rationally Designed Small Molecules That Target Both the DNA and RNA Causing Myotonic Dystrophy Type 1. Journal of the American Chemical Society. PMID 26473464 DOI: 10.1021/Jacs.5B09266 |
0.593 |
|
2014 |
Nguyen L, Lee J, Wong CH, Zimmerman SC. Small molecules that target the toxic RNA in myotonic dystrophy type 2. Chemmedchem. 9: 2455-62. PMID 24938413 DOI: 10.1002/Cmdc.201402095 |
0.682 |
|
2014 |
Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor. Journal of the American Chemical Society. 136: 6355-61. PMID 24702247 DOI: 10.1021/Ja5012146 |
0.657 |
|
2014 |
Nguyen L, Lee J, Wong C, Zimmerman SC. Cover Picture: Small Molecules that Target the Toxic RNA in Myotonic Dystrophy Type 2 (ChemMedChem 11/2014) Chemmedchem. 9: 2393-2393. DOI: 10.1002/Cmdc.201490040 |
0.649 |
|
2013 |
Jahromi AH, Fu Y, Miller KA, Nguyen L, Luu LM, Baranger AM, Zimmerman SC. Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1. Journal of Medicinal Chemistry. 56: 9471-81. PMID 24188018 DOI: 10.1021/Jm400794Z |
0.698 |
|
2013 |
Jahromi AH, Nguyen L, Fu Y, Miller KA, Baranger AM, Zimmerman SC. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1. Acs Chemical Biology. 8: 1037-43. PMID 23480597 DOI: 10.1021/Cb400046U |
0.71 |
|
Show low-probability matches. |